MaxCyte
MXCT
116 hedge funds and large institutions have $198M invested in MaxCyte in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 14 closing their positions.
60% more capital inflows, than outflows
Capital inflows: $30M | Capital outflows: $18.7M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.65% less ownership
Funds ownership: 68.83% → 68.18% (-0.65%)
3% less funds holding
Funds holding: 119 → 116 (-3)
11% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 44
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$10.2M |
| 2 |
GA
Gagnon Advisors
New York
|
+$3.68M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$3.51M |
| 4 |
Gagnon Securities
New York
|
+$3.36M |
| 5 |
Cadian Capital Management
New York
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.37M |
| 2 |
Portolan Capital Management
Boston,
Massachusetts
|
-$4.72M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.05M |
| 4 |
Goldman Sachs
New York
|
-$916K |
| 5 |
Swedbank
Stockholm,
Sweden
|
-$828K |
MXCT Hedge Fund Activity: Q1 2025 in Review
116 of the 7,488 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q1 2025, worth a combined $198M — down 35% from $303M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of MXCT and 12 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 39 added.
The largest buyer was Morgan Stanley, adding an estimated $10.2M. The largest seller was Millennium Management, cutting an estimated $5.37M.
- 116 institutional investors held MaxCyte (MXCT) as of Q1 2025, down from 119 in Q4 2024.
- Funds reported $198M of MaxCyte stock for Q1 2025, down 35% quarter-over-quarter.
- 12 funds opened new MaxCyte positions in Q1 2025 and 14 closed out, a net change of -2 holders.
- The largest MaxCyte buyer in Q1 2025 was Morgan Stanley, an estimated $10.2M added.
- The largest MaxCyte seller in Q1 2025 was Millennium Management, an estimated $5.37M sold.
Based on aggregated 13F filings for Q1 2025.